DrugPatentWatch Database Preview
VABOMERE Drug Profile
Which patents cover Vabomere, and what generic alternatives are available?
Vabomere is a drug marketed by Rempex Pharms and is included in one NDA. There are four patents protecting this drug.
This drug has twenty-two patent family members in seventeen countries.
The generic ingredient in VABOMERE is meropenem; vaborbactam. There are thirty-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the meropenem; vaborbactam profile page.
Summary for VABOMERE
| International Patents: | 22 |
| US Patents: | 4 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 1 |
| Clinical Trials: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for VABOMERE |
| Prior Art and Litigation Support | Order Prior Art and Litigation support for VABOMERE |
| DailyMed Link: | VABOMERE at DailyMed |
Generic Entry Opportunity Date for VABOMERE
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Synonyms for VABOMERE
| 2031124-72-6 |
| Carbavance |
| Meropenem / vaborbactam |
| Meropenem and vaborbactam |
| Meropenem mixture with vaborbactam |
US Patents and Regulatory Information for VABOMERE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rempex Pharms | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Rempex Pharms | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Rempex Pharms | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Rempex Pharms | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for VABOMERE
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Mexico | 348653 | ➤ Sign Up |
| European Patent Office | 2603514 | ➤ Sign Up |
| Spain | 2691468 | ➤ Sign Up |
| Colombia | 6680667 | ➤ Sign Up |
| European Patent Office | 3412676 | ➤ Sign Up |
| Country | Patent Number | Estimated Expiration |
